A ‘secret’ patch shows the future of treating the most common food allergy, and two biotechs are competing to own the $3 billion market Posted by Genevieve Klien in biotech/medical, health 12.09.2018 Kids with peanut allergies haven’t had many options, but that first-of-their-kind treatments could change that as soon as 2019. Read more